4-Fluoro-2-(trifluoromethyl)phenol | CAS:130047-19-7

We serve 4-Fluoro-2-(trifluoromethyl)phenol CAS:130047-19-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Fluoro-2-(trifluoromethyl)phenol

Chemical Name:4-Fluoro-2-(trifluoromethyl)phenol
CAS.NO:130047-19-7
Synonyms:4-Fluoro-2-(trifluoromethyl)phenol
5-Fluoro-2-hydroxybenzotrifluoride
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 169.3±35.0 °C at 760 mmHg
Molecular Formula C7H4F4O
Molecular Weight 180.100
Flash Point 56.2±25.9 °C
Vapour Pressure 1.2±0.3 mmHg at 25°C
Index of Refraction 1.440
 
Specification:
Appearance:Off-white crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 4-Fluoro-2-(trifluoromethyl)phenol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Fluoro-2-hydroxybenzotrifluoride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Fluoro-2-(trifluoromethyl)phenol Use and application,4-Fluoro-2-(trifluoromethyl)phenol technical grade,usp/ep/jp grade.


Related News: With the structural upgrade of the pharmaceutical industry in developed countries, the transfer of related industrial chains has taken place globally, and it has also had a profound impact on Chinese pharmaceutical companies. nearEthyl 2-Bromooctanoate manufacturer With the structural upgrade of the pharmaceutical industry in developed countries, the transfer of related industrial chains has taken place globally, and it has also had a profound impact on Chinese pharmaceutical companies. near1-Methylindole supplier The World Health Organisation (WHO) describes coronaviruses as a large family of viruses ranging from the common cold to more severe diseases such as Severe Acute Respiratory Syndrome (SARS), which killed nearly 800 people globally during a 2002/03 outbreak that also started in China.1-((4-Aminobenzenemethane)sulfonyl)pyrrolidine vendor The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.Remogliflozin is economical than other similar agents currently available in sodium glucose co-transporter-2 (SGLT2) inhibitors class, which shall help for its better access among middle and low socio-economic strata of the society, he added.